709 related articles for article (PubMed ID: 24691105)
1. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
Singal AG; Pillai A; Tiro J
PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
[TBL] [Abstract][Full Text] [Related]
2. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
[TBL] [Abstract][Full Text] [Related]
3. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
4. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
[TBL] [Abstract][Full Text] [Related]
5. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review.
Singal AG; Yopp A; S Skinner C; Packer M; Lee WM; Tiro JA
J Gen Intern Med; 2012 Jul; 27(7):861-7. PubMed ID: 22215266
[TBL] [Abstract][Full Text] [Related]
6. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
[TBL] [Abstract][Full Text] [Related]
8. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.
Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG
Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272
[TBL] [Abstract][Full Text] [Related]
9. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue.
Zhao C; Jin M; Le RH; Le MH; Chen VL; Jin M; Wong GL; Wong VW; Lim YS; Chuang WL; Yu ML; Nguyen MH
Liver Int; 2018 Mar; 38(3):503-514. PubMed ID: 28834146
[TBL] [Abstract][Full Text] [Related]
10. Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
Kim HY; Nam JY; Lee JH; Lee HA; Chang Y; Lee HY; Cho H; Lee DH; Cho YY; Cho EJ; Yu SJ; Lee JM; Kim YJ; Yoon JH
Aliment Pharmacol Ther; 2018 Jun; 47(11):1490-1501. PubMed ID: 29611209
[TBL] [Abstract][Full Text] [Related]
11. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
[TBL] [Abstract][Full Text] [Related]
15. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
J Gastroenterol Hepatol; 2020 Oct; 35(10):1795-1803. PubMed ID: 32222111
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma among cirrhotics--utility of screening and surveillance programs--review article.
Opriță R; Diaconescu IB; Lupu G; Lupu A; Cristea B; Bratu MR
J Med Life; 2014; 7(4):477-80. PubMed ID: 25713606
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
[TBL] [Abstract][Full Text] [Related]
19. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
20. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]